Delivery Order SPE2DB24D2212-SPE2DB25FHQLS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,167.80 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a $13,503.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive delivery order executed under an existing contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,134.56 for 60-tablet units of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. This competitively awarded, firm fixed-price delivery order was established on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation,...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.56 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and utilized firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract vehicle, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price delivery order, valued at $6,234.74, was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The award utilized no set-aside provisions and was competitively awarded to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,350.95 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used to treat cardiac arrhythmias. This competitive, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order utilizes firm fixed pricing and represents a child contract under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,801.61 for 60-count tablets of MULTAQ 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed price terms. This delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,586.58 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price contract was competitively awarded without set-aside designation and is set for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,529.88 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. Issued on August 8, 2025, with an ultimate completion date of August 11, 2025, this firm fixed-price contract represents a non-set-aside award made through open competition. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQLSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,809.04 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion potential value through December 2026. As a child contract under this comprehensive pharmaceutical support vehicle, the delivery order contributes to the company's role as a critical supplier of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its established capability to fulfill federal medical procurement requirements through competitive selection and its significant role within the DLA's pharmaceutical distribution network serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.8k | 8/5/25 |